A Study of Lurasidone HCl in Subjects With Schizophrenia
Clinical trial NCT03393026 · COMPLETED
Trial details
- NCT number
- NCT03393026
- Sponsor
- Standard Chem. & Pharm. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-03
- Primary completion
- 2019-09-17
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.